more
chasing
squirr
els,
m
ore
m
eet
a
n
d
g
r
e
e
ts
,
mo
re
ca
r
r
i
d
es
,
M
or
e
ra
c
es
t
h
r
o
u
g
h
t
he
park,
Mo
r
e
b
i
rd
W
A
e
ts
,
mo
re
ca
r
r
i
d
es
,
M
or
e
ra
c
es
t
h
r
o
u
g
h
t
h
t
h
t
e
park,
Mo
r
e
b
i
rd
more
chasing
squirr
els,
m
ore
m
eet
a
n
a
n
a
d
g
r
e
e
t
Talk to your
Merck Animal Health
representative to
learn more.
us.bravecto.com
PROTECTION
THAT GOES LOOONG
We know compliance can be tough for clients. That's
why a single dose of BRAVECTO® Chews lasts nearly
3x longer than a single dose of monthly flea and tick
products.
1
Give your clients less to worry about
and your patients more between doses.*
(fluralaner)
Chews
Copyright © 2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. US-BRV-221000015 874755
* Compared to monthly products.
†
BRAVECTO (fluralaner) Chews for Dogs kills fleas, prevents flea infestations, and kills ticks
(black-legged tick, American dog tick, brown dog tick, and Asian longhorned tick) for 12 weeks.
BRAVECTO Chews also kills lone star ticks for 8 weeks.
Reference: 1. BRAVECTO® Chews. Product label. Merck Animal Health; 2022.
IMPORTANT SAFETY INFORMATION: BRAVECTO (fluralaner) Chews for Dogs: The most commonly
reported adverse reactions include vomiting, lethargy, diarrhea, anorexia and pruritus. In some cases,
adverse events have been reported following use in breeding females. BRAVECTO Chews has not been
shown to be effective for 12-weeks' duration in puppies less than 6 months of age. BRAVECTO Chews is not
effective against lone star ticks beyond 8 weeks of dosing. Fluralaner is a member of the isoxazoline class.
This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures.
Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of
seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Please see full product
information.
